全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

小儿脓毒症高血糖机制及治疗研究进展
Research Progress on Mechanism and Treatment of Hyperglycemia in Children with Sepsis

DOI: 10.12677/ns.2024.136113, PP. 790-794

Keywords: 小儿,脓毒症,高血糖,研究进展
Children
, Sepsis, Hyperglycemia, Research Progress

Full-Text   Cite this paper   Add to My Lib

Abstract:

脓毒症是儿童常见的临床重症感染性疾病,其病情严重并发展快,可引起脓毒症休克和多器官功能衰竭,因此有较高的死亡率。脓毒症患儿通常伴有血糖升高,与体内代谢功能紊乱有关,因而高血糖为脓毒症患儿体内代谢功能失调的重要评价指标。脓毒症患儿血糖升高与应激状态、严重感染、胰岛素相对分泌不足以及胰腺功能受损有关。高血糖作为脓毒症患儿死亡的独立危险因素,不仅对患儿治疗和康复产生不良影响,严重时可导致患儿死亡,因此,对脓毒症伴高血糖患儿的血糖进行有效控制尤为重要。本文将从脓毒症患儿高血糖的发作机制、高血糖对脓毒症患儿的影响及胰岛素在高血糖中的应用等方面进行探究。
Sepsis is a common clinical severe infectious disease in children, which is serious and develops rapidly, can cause septic shock and multiple organ failure, and has a high mortality. Children with sepsis are usually accompanied by elevated blood sugar, which is related to metabolic dysfunction in the body. Therefore, hyperglycemia is an important evaluation index of metabolic dysfunction in children with sepsis. Elevated blood sugar in children with sepsis is associated with stress, severe infection, relative insufficiency of insulin secretion, and impaired pancreatic function. As an independent risk factor for the death of children with sepsis, hyperglycemia not only has adverse effects on the treatment and rehabilitation of children with sepsis, but also can lead to death in severe cases. Therefore, it is particularly important to effectively control the blood sugar of children with sepsis and hyperglycemia. This paper will explore the attack mechanism of hyperglycemia in children with sepsis, the influence of hyperglycemia on children with sepsis, and the application of insulin in hyperglycemia.

References

[1]  钱淑媛, 乔兴田, 王皓飞, 谢剑锋, 刘应叶, 周娟, 李晓青. 基于人工智能的血糖控制方案对脓毒症患者血糖控制的影响[J]. 当代护士(下旬刊), 2022, 29(7): 40-44.
[2]  吕瑶瑶, 王莹, 焦海妮, 冀海侠, 王伟娟. 糖代谢紊乱与重症肺炎合并脓毒症患者病情及预后的关系[J]. 疑难病杂志, 2021, 20(2): 148-152, 157.
[3]  姚桂爱, 潜丽俊. 胰岛素早期强化治疗对儿童脓毒症患者血管内皮功能的保护作用[J]. 中国现代医生, 2018, 56(9): 17-20.
[4]  张超, 曹雪琴, 赵辉, 崔可, 王锦栋. 血清sRAGE、HbA_(1C)表达与脓毒症患者应激性高血糖及其预后相关性[J]. 广东医学, 2021, 42(11): 1328-1331.
[5]  王翠敏. 甲泼尼龙联合目标液体复苏治疗小儿脓毒症休克的临床观察[J]. 黑龙江医药, 2021, 34(2): 336-337.
[6]  关则想, 李红, 白婷, 麦益友. 低剂量糖皮质激素辅助治疗小儿脓毒症的临床效果及对炎症因子水平的影响[J]. 内科, 2020, 15(1): 78-80.
[7]  朱莲, 潜丽俊. 早期强化胰岛素治疗对儿童脓毒症患者肠黏膜屏障功能的影响[J]. 中国现代医生, 2018, 56(23): 46-48, 52.
[8]  冉建瑜, 李仲霞, 黎德郡. 小儿脓毒症心肌损伤的临床治疗研究进展[J]. 中外医疗, 2019, 38(8): 188-190, 194.
[9]  张明英. 小儿脓毒症高血糖机制及治疗研究进展[J]. 继续医学教育, 2022, 36(7): 161-164.
[10]  吕卓超, 潜丽俊. 早期胰岛素强化治疗儿童脓毒症的疗效及对氧化应激的影响[J]. 中国现代医生, 2019, 57(02): 8-11.
[11]  范路梅, 魏红, 谢小红. 胰岛素不同给药方式对脓毒症伴高血糖患者血糖控制、不良事件的影响[J]. 罕少疾病杂志, 2019, 26(6): 38-40.
[12]  张玲玲, 王颖. 糖尿病和入院高血糖对严重脓毒症患者预后的影响[J]. 临床急诊杂志, 2020, 21(4): 323-326.
[13]  王静蓉, 皇鑫. 高血糖状态对脓毒症患者肠道菌群影响[J]. 中国卫生产业, 2018, 15(35): 144-145, 148.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133